Time-dependent antagonist-agonist switching in receptor tyrosine kinase-mediated signaling
Abstract Background ErbB4/HER4 is a unique member of the ErbB family of receptor tyrosine kinases concerning its activation of anti-proliferative JAK2-STAT5 pathway when stimulated by ligand Neuregulin (NRG). Activation of this pathway leads to expression of genes like β-casein which promote cell di...
Main Authors: | Alokendra Ghosh, Ravi Radhakrishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-019-2816-3 |
Similar Items
-
Role of janus kinase inhibitors in the treatment of alopecia areata
by: Triyangkulsri K, et al.
Published: (2018-07-01) -
Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCG
by: Hisataka Moriwaki, et al.
Published: (2008-06-01) -
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
by: Nicholas P. D. Liau, et al.
Published: (2019-11-01) -
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
by: Qianqian Yin, et al.
Published: (2021-09-01) -
Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury
by: Kylie A. Alexander, et al.
Published: (2019-03-01)